Butaperazine (Repoise).
D002908:Chronic Disease; D002986:Clinical Trials as Topic; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D010546:Perphenazine / Q000627:therapeutic use; D010640:Phenothiazines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010879:Piperazines / Q000627:therapeutic use*; D011346:Prochlorperazine / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D014149:Tranquilizing Agents / Q000627:therapeutic use*; D014268:Trifluoperazine / Q000627:therapeutic use
D010640:Phenothiazines; D010879:Piperazines; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D010546:Perphenazine; D006220:Haloperidol; D011346:Prochlorperazine